Series F - AliveCor

Series F - AliveCor

Investment Firm

Overview

AliveCor is a FDA-cleared mobile heart solution that helps save lives, save money, and brings healthcare into the 21st century.

Announced Date

Aug 16, 2022

Funding Type

Series F

Highlights

Location

United States, North America

Social

Investor Lead

GE Healthcare

GE Healthcare

No designation

Participant Investors

5

Investor Name
Participant InvestorWP Global Partners
Participant InvestorGE Healthcare
Participant InvestorBold Capital Partners
Participant InvestorQualcomm Ventures
Participant InvestorKhosla Ventures

Round Details and Background

AliveCor raised an undisclosed amount on 2022-08-16 in Series F

AliveCor is a FDA-cleared mobile heart solution that helps save lives, save money, and brings healthcare into the 21st century.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 16, 2022
Series F - AliveCor
6-undefined
Mar 15, 2017
Series D - AliveCor
2-30.0M
Jun 10, 2012
Series B - AliveCor
5-10.5M
Aug 02, 2011
Series A - AliveCor
3-3.0M

Recent Activity

There is no recent news or activity for this profile.